Firefly Neuroscience Inc (AIFF)

Form EFFECT - Notice of Effectiveness

Form PRE 14A - Other preliminary proxy statements

Form 8-K - Current report

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Form 8-K - Current report

Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD

– Comes just weeks after Firefly confirmed its active public-private partnership with the U.S. Department of...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form S-3 - Registration statement under Securities Act of 1933

Form 8-K - Current report

Form 8-K - Current report

Form D - Notice of Exempt Offering of Securities

With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository

- Firefly’s total brain scan volumes have increased sequentially by higher percentages in each of the past four...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Firefly partners with U.S. Defense Department on PTSD and TBI evaluation

Firefly Neuroscience, Inc. (NASDAQ:AIFF) said it has entered into a partnership with the U.S. Department of Defense to support the evaluation and...

Firefly Confirms Public-Private Partnership with the Department of War

Firefly’s AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of...